Private Asset Management Inc Heron Therapeutics, Inc. Transaction History

Private Asset Management Inc

$419 Million
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 04, 2022	SELL	$4.63 - $9.94 $360,403 - $773,739	-77,841 Closed	0 $0
Q4 2021 Jan 03, 2022	SELL	$8.35 - $12.6 $492,766 - $743,576	-59,014 Reduced 43.12%	77,841 $711,000
Q3 2021 Oct 04, 2021	SELL	$10.13 - $15.0 $410,295 - $607,545	-40,503 Reduced 22.84%	136,855 $1.46 Million
Q2 2021 Jul 06, 2021	SELL	$13.27 - $18.48 $205,618 - $286,347	-15,495 Reduced 8.03%	177,358 $2.75 Million
Q1 2021 Apr 02, 2021	BUY	$14.49 - $20.72 $323,692 - $462,864	22,339 Added 13.1%	192,853 $3.13 Million
Q4 2020 Jan 05, 2021	SELL	$14.61 - $22.14 $7,451 - $11,291	-510 Reduced 0.3%	170,514 $3.61 Million
Q3 2020 Oct 06, 2020	BUY	$13.67 - $17.77 $332,796 - $432,610	24,345 Added 16.6%	171,024 $2.54 Million
Q2 2020 Jul 06, 2020	BUY	$10.89 - $21.47 $171,942 - $338,989	15,789 Added 12.06%	146,679 $2.16 Million
Q1 2020 Apr 02, 2020	BUY	$10.23 - $24.56 $157,746 - $378,715	15,420 Added 13.35%	130,890 $1.54 Million
Q4 2019 Jan 03, 2020	BUY	$17.42 - $26.61 $259,035 - $395,690	14,870 Added 14.78%	115,470 $2.71 Million
Q3 2019 Oct 02, 2019	SELL	$16.36 - $21.39 $40,900 - $53,475	-2,500 Reduced 2.61%	93,450 $1.74 Million
Q3 2019 Oct 02, 2019	BUY	$16.36 - $21.39 $116,974 - $152,938	7,150 Added 7.65%	100,600 $1.86 Million
Q2 2019 Jul 02, 2019	BUY	$16.93 - $26.22 $59,170 - $91,638	3,495 Added 3.78%	95,950 $1.78 Million
Q1 2019 Apr 03, 2019	SELL	$23.15 - $28.34 $33,035 - $40,441	-1,427 Reduced 1.52%	92,455 $2.26 Million
Q4 2018 Jan 08, 2019	BUY	$22.03 - $32.01 $57,828 - $84,026	2,625 Added 2.88%	93,882 $2.44 Million
Q3 2018 Oct 02, 2018	SELL	$30.0 - $40.85 $74,790 - $101,839	-2,493 Reduced 2.66%	91,257 $2.89 Million
Q2 2018 Jul 23, 2018	SELL	$26.4 - $42.0 $104,940 - $166,950	-3,975 Reduced 4.07%	93,750 $3.64 Million
Q2 2018 Jul 10, 2018	BUY	$26.4 - $42.0 $69,300 - $110,250	2,625 Added 2.76%	97,725 $2.7 Million
Q1 2018 Apr 06, 2018	BUY	$18.43 - $28.8 $149,743 - $234,000	8,125 Added 9.34%	95,100 $2.63 Million
Q4 2017 Jan 05, 2018	BUY	$14.8 - $18.85 $844,340 - $1.08 Million	57,050 Added 190.64%	86,975 $1.57 Million
Q3 2017 Oct 04, 2017	BUY	$14.65 - $16.85 $431,325 - $496,097	29,442 Added 6095.65%	29,925 $483,000
Q3 2017 Oct 03, 2017	BUY	$14.65 - $16.85 $7,075 - $8,138	483	483 $483 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Asset Management Inc with notifications on news.

Account